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Abstract. Radiation therapy produces Cherenkov optical
emission in tissue, and this light can be utilized to activate
molecular probes. The feasibility of sensing luminescence
from a tissue molecular oxygen sensor from within a
human body phantom was examined using the geometry
of the axillary lymph node region. Detection of regions
down to 30-mm deep was feasible with submillimeter spatial resolution with the total quantity of the phosphorescent
sensor PtG4 near 1 nanomole. Radiation sheet scanning
in an epi-illumination geometry provided optimal coverage,
and maximum intensity projection images provided illustration of the concept. This work provides the preliminary
information needed to attempt this type of imaging in
vivo. © The Authors. Published by SPIE under a Creative Commons

of this luminescence lifetime sensing technology in human
imaging.
Cherenkov radiation is produced in all tissues undergoing
treatment with Megaelectron Volt photons or electrons,3 generating broadband optical radiation that can be used to excite
molecular probes.4,5 Clinical linear accelerators (linacs) operate
in pulsed mode with ∼4-μs bursts,6,7 allowing for excitation of
phosphorescent probes that have 10- to 100-μs range emission
decay times.8 Previous experiments demonstrated this luminescence imaging with Cherenkov excitation in basic tissue phantoms and in rodents,9,10 to image tissue oxygenation, with timegated signals that were sensitive to the luminescence quenching
by oxygen. The key advantage of the method was to image centimeters into tissue while retaining submillimeter spatial resolution. At the same time, imaging oxygen is relevant in
radiotherapy since it is a radiosensitivity factor that correlates
with outcome.11
In this work, sheet-shaped radiation beams from a linac were
used to produce Cherenkov photons, to excite luminescence of
probes in a volume largely confined to the irradiation sheets.
Thus, by shaping the x-ray beam into a thin sheet, images of
Cherenkov-excited luminescence from a planar slice within
the tissue can be observed. Analogous to light sheet microscopy,
a series of luminescence images can be taken at different depths,
allowing for three-dimensional (3-D) volumetric rendering. This
imaging approach has been termed Cherenkov-excited luminescence scanned imaging (CELSI).2,10 Knowing the position of the
excitation plane allows for depth-variant attenuation correction,
and postprocessed 3-D images show the luminescence distribution from within the tissue.
The aim of this study was to study CELSI in a human body
geometry, to demonstrate the capability of imaging local
oxygenation in regions similar in size to lymph nodes, as
shown in Fig. 1. Specifically, the effects of depth, concentration,
and minimum radiation dose were examined here.
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Introduction

All optical imaging techniques suffer from diminished spatial
resolution with increasing depth into tissue because of the severe
light scattering present.1 Yet, in recent studies it has been shown
that Cherenkov-based excitation of molecular probes is a feasible way to image deep into tissues, over several centimeters,
with submillimeter resolution.2 One important application of
this is luminescence-based sensing of oxygen over macroscopic
depths into tissue. The available depth of sampling is appropriate for imaging oxygenation in lymph nodes. In this study,
the feasibility of imaging oxygen in lymph node-sized objects
in a human body phantom was assessed to estimate applicability

*Address all correspondence to: Brian W. Pogue, E-mail: brian.w.pogue@
dartmouth.edu
†

Equal contribution.
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Phantoms and Geometry

Depth and concentration range evaluation experiments were carried out to assess the signal-to-noise ratio (SNR) and signal-tobackground ratio for phosphorescent objects at varying depths.
The phosphorescent probe used in our experiments was PtG4,
which has a well-demonstrated oxygen-dependent luminescence
lifetime, characterized in solution12 as well as in our previous
animal study.2 Eppendorf tubes containing 0.5-mL solution of
PtG4 of varying concentrations (1 to 100 μM) were positioned
at different depths (0 to 3.5 cm) to assess imaging capability
with concentration and depth. A semi-infinite tissue phantom,
of 1% aqueous solution of intralipid and 1% bovine blood
was used to mimic the optical properties of the human tissue.
A full torso PBU-50 phantom (Kyoto Kagaku America Inc.,
Torrance, California) was used with two sets of measurements.
First, Eppendorf tubes were used with 50 μL of 25-μM solution
of PtG4 (0.5 nanomoles) in phosphate buffered saline (PBS),
and comparing with controls of just PBS and an empty tube.
In the second set, five 0.2-mL Eppendorf tubes were used,
each containing (1) 50 μL of solution of PtG4 at concentrations:
1, 5, 10, 20, and 25 μM, for total quantities of 0.05, 0.25, 0.5,
1.0, and 1.25 nanomoles, respectively. The tubes were placed in
the lateral rib region of the phantom at a sufficient distance from
one another to prevent spatial overlap of their signals.
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linac gantry oriented at 145 deg and in the same side as the
ICCD. The ICCD gate delays and widths were adjusted with
0.05 μs delay and 4 μs width for Cherenkov imaging, whereas
a 4.2 μs delay and 70 μs width was used for phosphorescence
imaging, and 1500 μs delay and 70 μs width used for background. Cherenkov, phosphorescence, and background images
were acquired with 100× gain on the intensifier. The image
intensifier was gated by a predefined number of pulses, whereas
the CCD integrated the signal prior to readout. Different values
of this approach to accumulations on the chip (AoC) were used
for each of the Cherenkov, phosphorescence, and background
images for all body phantom CELSI experiments. Room-light
images were acquired with 1× gain and 1 AoC. An 8-MHz analog-to-digital conversion rate was used with 2 × 2 pixel hardware binning upon readout, resulting in 512 × 512 pixel images.

2.4

Fig. 1 Measurement geometry for the body phantom is shown with
(a) a schematic of the geometry, (b) a photograph of the setup,
and (c) the body phantom with skin on (left) and without skin
(right) as shown with five tubes fixed onto the lateral rib area.

In both experimental sets, the phantom was imaged both with
and without “skin layer” that was mimicked using tissue colored
modeling clay (SuperSculpey® Original). Prior to the CELSI
experiments, we validated the tissue-like optical properties of the
used modeling clay by measuring its absorption and scattering
coefficients.13 Using a custom tissue spectroscopy device, the
DOSI system,14 we measured values across the spectral range
of 650 to 1000 nm. The spectral range of PtG4 phosphorescence
emission is peaked at 772 nm, the absorption and scattering coefficients of the clay (μa ¼ 0.014 mm−1 , μs0 ¼ 0.55 mm−1 match
reasonable values of skin and/or adipose human tissue. A clinical
x-ray CT of the body phantom, with 2.5-mm slice thickness,
was obtained to facilitate postprocessing image overlay
(LightSpeedCT, GE Healthcare, Chicago, Illinois).

2.2

Linear Accelerator

In each experiment, a Varian linac (2100CD, Varian Medical
Systems, Palo Alto, California) was used to deliver six MV xray photon beams to the phantoms in the form of thin sheets.
Multileaf collimators (MLC) (Millennium 120MLC, Varian
Medical Systems) were used to shape and vertically translate the
beam profile adaptively. Each sheet was 200-mm wide and 5-mm
thick. The MLC leaves translated a total distance of 50 mm with a
0.2-mm step—this resulted in a total of 250 x-ray sheet positions
along the length of the treatment area. The maximum dosage of
radiation delivered by the linac was 20 MU/position, with up to
25 overlapping positions (5 mm moved in steps of 0.2 mm); this
resulted in a maximum of 20 × 25 ¼ 500 MU being delivered to
the volume as defined by a single beam sheet—roughly equivalent to a maximum absorbed dose of 5 Gy.

2.3

Luminescence Emission Imaging

Images were captured by a gated, intensified charge-coupled
device (ICCD, PI-MAX4 1024i, Princeton Instruments) with
a 135-mm lens (Nikon), using the associated LightField software. An epi-illumination configuration was used, with the
Journal of Biomedical Optics

Image Processing

Image processing was carried out in MATLAB and Python. The
protocol first involved background subtraction, followed by a
depth stack (z-stack) median filter, across four frames in
sequence, resulting in 250 frames. Next, each image was background corrected relative to its own residual background by subtracting the median from a background region of each image in
the z-stack, followed by a 2-D (5 × 5) and a 3-D (5 × 5 × 5) spatial median filter. Finally, a 3-D Gaussian Filter with FWHM ¼
4.7pixels was applied. Maximum-intensity projection (MIP)
images were generated along the z-stack. The processed images
were overlaid on the room-light image using both ImageJ and
MATLAB Overlay GUI.15 Subsequently, videos were generated
using ImageJ, showing the translation of the sheet beam through
the region containing the simulated lymph nodes and static
images of these are shown in Fig. 3.
Image display was done for 3-D views in Paraview (Kitware
Inc.), using the processed phosphorescence image stack and the
MIP images from the final two sets of tube experiments.
Specifically, the experiments conducted with simulated skin
were used for the 3-D reconstructions. The images were registered using the centroids of the Eppendorf tubes and edge of the
phantom as fiducials to coalign the co-ordinate system of the CT
to that of the phosphorescence images.

3

Results

In the depth and concentration ranging studies, CELSI experiments were performed for an intralipid-blood phantom
embedded with PtG4-containing 0.5-mm Eppendorf tubes. The
results are shown in Fig. 2, where sample luminescence and
roomlight images are included in (a), and SNR is plotted in (b).
The SNR has an exponential shape and the values plateau to
their lowest values at deeper depths, as anticipated, because
at some extreme depths the presence of the luminescent region
cannot be sensed. Consequently, the SNR should be expected to
asymptote to 1.0 at deep depths. The relationship between imaging depth and concentration of PtG4 for SNR ¼ 1 is described
by the circled plots in Fig. 2(b), indicating that for depths
<1.7 cm there was good SNR, but below this depth, the concentration required for SNR > 1 increased dramatically. However,
signal as deep at 3 cm was detectable, at concentrations just
above 100 microMolar.
For the first set of geometry studies investigating phosphorescence of tubes containing PtG4 relative to control tubes
containing PBS and a blank, a strong phosphorescent signal
was detected. This was anticipated because the stock solution
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Fig. 2 Experimental results to investigate image quality versus depth
for different concentrations of PtG4 (CPtG4 ) as shown in the legend,
showing (a) the room light image and luminescence images of the
phantom used at three different depths in the phantom, and (b) the
corresponding SNR values extracted from these images are shown
as a function of depth by colored dots. In the same graph, the red
line shows the CPtG4 at which SNR ¼ 1 (values on left y -axis).

(b)
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Fig. 4 3-D images of (a) CT and (b) overlaid with CELSI for three
orthogonal views: coronal, sagittal, and transverse. Compositions
of CT and CELSI images for varying numbers of light sheets,
which correspond to less dose delivery. In these images, the number
of sheets were: (c) 25, (d) 50, (e) 100, and (f) 250, respectively.

Slice #126

(b)

(c)
Fig. 3 Raw measurement sequences are shown for (a) Cherenkov
emission and (b) luminescence photons, for the sheet at four different
slice locations. In (c) a composition image is shown of the phantom CT
with color overlay of the CELSI MIP image. A temporal sweep of the
signals in (a) and (b) can be seen in the associated video files as the
sheet moved across the phantom body.

of 25 μM was a high concentration and was placed at a depth of
only 3 mm. At 144 AoC, the SNR was computed to be 59,
whereas at 60 AoC the SNR was 66. Overall, the 144 and
60 AoC cases produced similar results, with very similar
SNRs, for the experiments with “skin.”
For the second set of experiments investigating different
concentrations of PtG4, visible phosphorescent signals were
detected from the 5- to 25-μM tubes, whereas the 1-μM
tube did not produce a signal with sufficient SNR to be detected.
The trend in signal strength, with respect to concentrations on
the MIP images was as anticipated, with greater concentrations
of PtG4 yielding stronger, brighter signals, with slight variation
Journal of Biomedical Optics

(d)

largely due to the thickness of skin overlying the tubes. Videos
of the two sets of geometry studies are illustrated.
The angular sheet-beam scanning methodology that is more
suitable for imaging a chest region was used, as shown in Fig. 1.
Raw measurements of Cherenkov light and luminescence for
four specific slice positions are shown in Figs. 3(a) and 3(b),
respectively. Figure 3(c) shows a combined image of CT and
luminescence maximum intensity projection (MIP). Scanned
image data were reprocessed and overlaid on the 3-D volume
of the CT scan, to allow visualization of the recovered positions
of the tubes. The recovered images are shown in Fig. 4, with a
perspective view in (a), and the three orthogonal views of the CT
in (b).
To pursue a minimum radiation dose, sparse illumination was
investigated, i.e., the number of light sheets was desired to be as
few as possible. Here, a total of 25, 50, 100, and 250 light sheets
were used with equal spacing, i.e., with spaces 2, 1, 0.5, and
0.2 mm, respectively. Figures 4(c)–4(f) show the compositions
of CT and CELSI images for different numbers of light sheet. It
can be seen that the image quality was reasonable, even for 25
light sheets.

4

Discussion

Initial studies of depth sensitivity have indicated that CELSI imaging would be viable for a depth of perhaps 2 to 3 cm, likely
dependent upon the tissue type involved. Adipose tissues tend to
have lower blood volume and consequently reduced absorption
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attenuation of the light—this may allow imaging down to 3 cm.
In contrast, denser tissues would have higher absorption and
therefore be more limited to >2 cm.
The set of experiments conducted here were initially focused
on determining the optimum positioning of the body phantom,
couch, gantry, and camera for maximal sensitivity. Three orientations were investigated such as (i) vertical with the gantry
directly above the body phantom on the couch at 180-deg reference angle and the camera placed directly facing the left side of
the body phantom, (ii) horizontal with the gantry directly facing
the left side of the body phantom at 90-deg reference angle and a
45-deg front-surface mirror placed above the top surface of the
body phantom, allowing horizontal mounting of the ICCD
directly facing the mirror, and (iii) angled with the gantry at
145-deg reference angle with ICCD on the same side. The angular orientation in an epi-illumination configuration was determined to be optimum and used for all subsequent experiments.
In this orientation, a Cherenkov sheet was clearly visible translating through the body phantom. This orientation was also
hypothesized to result in a strong phosphorescence signal from
the simulated lymph nodes, and better approximated tangential
breast tumor treatment protocol. The recovery of intensity was
highly modulated by the depth of tissue overlying the tubes, and
it was apparent that the signal was not linear with concentration
because of this effect. However with skin thickness measured by
the CT scan and geometry, it is feasible to quantify these values
based on depth-dependent attenuation correction.10
These studies illustrate how imaging of lymph node sized
objects may have potential with CELSI imaging in radiotherapy.
Sensing their oxygenation is feasible, and further exploration of
agents and signal analysis could lead to the next clinical trials in
molecular sensing in radiotherapy.
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